Euro vs US Dollar

Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.

Registrieren

ORIC Oric Pharmaceuticals Inc

7,49

-0,19 (-2,47%)

15 Jun 2024 - Geschlossen

Verzögert um 15 Minuten

Form EFFECT - Notice of Effectiveness

Oric Pharmaceuticals (NASDAQ:ORIC)
Historical Stock Chart
Von Mai 2024 bis Jun 2024

Click Here for more Oric Pharmaceuticals Charts.

Oric Pharmaceuticals (NASDAQ:ORIC)
Historical Stock Chart
Von Jun 2023 bis Jun 2024

Click Here for more Oric Pharmaceuticals Charts.

News Oric Pharmaceuticals Inc

Form 8-K - Current report
Freitag 14 Juni 2024 (23 Stunden vor) • Edgar (US Regulatory)

ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Freitag 7 Juni 2024 (1 Woche vor) • GlobeNewswire Inc.

ORIC Pharmaceuticals to Participate in Upcoming Investor Conferences
Mittwoch 29 Mai 2024 (2 Wochen vor) • GlobeNewswire Inc.

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Montag 6 Mai 2024 (1 Monat vor) • Edgar (US Regulatory)

Form 8-K - Current report
Montag 6 Mai 2024 (1 Monat vor) • Edgar (US Regulatory)

ORIC Pharmaceuticals Reports First Quarter 2024 Financial Results and Operational Updates
Montag 6 Mai 2024 (1 Monat vor) • GlobeNewswire Inc.

ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Freitag 3 Mai 2024 (1 Monat vor) • GlobeNewswire Inc.

ORIC Pharmaceuticals Announces First Patients Dosed Across Three Expansion Cohorts in Phase 1b Trial of ORIC-114 in Patients with Mutated NSCLC
Montag 15 April 2024 (2 Monate vor) • GlobeNewswire Inc.

ORIC Pharmaceuticals Presents Preclinical Data on Two Programs at the 2024 American Association for Cancer Research (AACR) Annual Meeting
Montag 8 April 2024 (2 Monate vor) • GlobeNewswire Inc.

ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Freitag 5 April 2024 (2 Monate vor) • GlobeNewswire Inc.

ORIC Pharmaceuticals to Participate in Upcoming Investor Conferences
Donnerstag 4 April 2024 (2 Monate vor) • GlobeNewswire Inc.

Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers
Montag 11 März 2024 (3 Monate vor) • Edgar (US Regulatory)

Weitere Oric Pharmaceuticals Inc News-Artikel

AB CarVal Opportunistic ...

Gabelli Value Plus+

Invesco Pennsylvania Val...

BNP Paribas Issuance

Bnp Paribas Issuance

Artis Real Estate Invest...

BNP Paribas Issuance

NanoTech Entertainment (CE)

BNP PARIBAS ISSUANCE

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen